WB | 咨询技术 | Human,Mouse,Rat |
IF | 咨询技术 | Human,Mouse,Rat |
IHC | IHC:1/100-1/200;IHF:1/50-1/200 | Human,Mouse,Rat |
ICC | 1/50-1/200 | Human,Mouse,Rat |
FCM | 1/20-1/100 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | Cathepsin; CTSL; CTSV; CTSK; CTSH;;Cathepsin L/V/K/H |
WB Predicted band size | Calculated MW: 37,38 kDa ; Observed MW: 38 kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human,Mouse,Rat |
Immunogen | A synthesized peptide derived from human Cathepsin L/V/K/H |
Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
1. **"Role of Cathepsin K in bone resorption and its inhibition by osteoprotegerin"**
*作者:Tezuka K, et al.*
摘要:研究阐明了Cathepsin K在破骨细胞介导的骨吸收中的关键作用,并开发了特异性抗体用于检测其在骨疾病模型中的表达,为骨质疏松治疗提供了靶点依据。
2. **"Cathepsin L in cancer progression: Antibody-based detection and therapeutic implications"**
*作者:Gocheva V, et al.*
摘要:通过新型单克隆抗体技术证实Cathepsin L在肿瘤转移中的促侵襲作用,抗体成功应用于临床前模型以抑制肿瘤微环境中的酶活性。
3. **"Differential expression of Cathepsin V in dendritic cells modulates antigen processing"**
*作者:Hsing LC, et al.*
摘要:研究利用多克隆抗体对比Cathepsin V与L在树突细胞中的分布差异,揭示其在MHC-II抗原递呈通路中的独特调控机制。
4. **"Cathepsin H as a biomarker in hepatocellular carcinoma: Validation of a high-affinity antibody panel"**
*作者:Kos J, et al.*
摘要:开发并验证了一组针对Cathepsin H的高特异性抗体,证实其在肝癌组织中的过表达与患者预后显著相关,提示其作为诊断标志物的潜力。
(注:以上为示例性虚构文献,实际引用需检索PubMed/Google Scholar获取真实数据。建议使用关键词如"Cathepsin [L/V/K/H] antibody" + "function/disease/therapy"进行精准筛选。)
×